| 1. | 
				                                                                				                                                                       
				                                                                        Carbone DP, Gandara DR, Antonia SJ,  et al. Non-small-cell lung cancer: role of the immune system and potential for immunotherapy. J Thorac Oncol, 2015, 10(7): 974-984.
				                                                                 | 
				                                                            
				                                                        
				                                                            
				                                                                | 2. | 
				                                                                				                                                                       
				                                                                        Wang DY, Salem JE, Cohen JV,  et al. Fatal toxic effects associated with immune checkpoint inhibitors: a systematic review and meta-analysis. JAMA Oncol, 2018, 4(12): 1721-1728.
				                                                                 | 
				                                                            
				                                                        
				                                                            
				                                                                | 3. | 
				                                                                				                                                                       
				                                                                        Haslam A, Prasad V. Estimation of the percentage of us patients with cancer who are eligible for and respond to checkpoint inhibitor immunotherapy drugs. JAMA Netw Open, 2019, 2(5): e192535.
				                                                                 | 
				                                                            
				                                                        
				                                                            
				                                                                | 4. | 
				                                                                				                                                                       
				                                                                        Friedman CF, Proverbs-Singh TA, Postow MA. Treatment of the immune-related adverse effects of immune checkpoint inhibitors: a review. JAMA Oncol, 2016, 2(10): 1346-1353.
				                                                                 | 
				                                                            
				                                                        
				                                                            
				                                                                | 5. | 
				                                                                				                                                                       
				                                                                        Tirumani SH, Ramaiya NH, Keraliya A,  et al. Radiographic profiling of immune-related adverse events in advanced melanoma patients treated with ipilimumab. Cancer Immunol Res, 2015, 3(10): 1185-1192.
				                                                                 | 
				                                                            
				                                                        
				                                                            
				                                                                | 6. | 
				                                                                				                                                                       
				                                                                        中华医学会呼吸病学分会肺癌学组. 免疫检查点抑制剂相关肺炎诊治专家共识. 中华结核和呼吸杂志, 2019, 42(11): 820-825.
				                                                                 | 
				                                                            
				                                                        
				                                                            
				                                                                | 7. | 
				                                                                				                                                                       
				                                                                        Chung M, Bernheim A, Mei XY,  et al. CT imaging features of 2019 novel coronavirus (2019-nCoV). Radiology, 2020, 295(1): 202-207.
				                                                                 | 
				                                                            
				                                                        
				                                                            
				                                                                | 8. | 
				                                                                				                                                                       
				                                                                        Johkoh T, Lee KS, Nishino M,  et al. Chest CT diagnosis and clinical management of drug-related pneumonitis in patients receiving molecular targeting agents and immune checkpoint inhibitors: a position paper from the Fleischner Society. Radiology, 2021, 298(3): 550-566.
				                                                                 | 
				                                                            
				                                                        
				                                                            
				                                                                | 9. | 
				                                                                				                                                                       
				                                                                        Nishino M, Sholl LM, Hodi FS,  et al. Anti-PD-1-related pneumonitis during cancer immunotherapy. N Engl J Med, 2015, 373(3): 288-290.
				                                                                 | 
				                                                            
				                                                        
				                                                            
				                                                                | 10. | 
				                                                                				                                                                       
				                                                                        Brahmer J, Reckamp KL, Baas P,  et al. Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer. N Engl J Med, 2015, 373(2): 123-135.
				                                                                 | 
				                                                            
				                                                        
				                                                            
				                                                                | 11. | 
				                                                                				                                                                       
				                                                                        Nishino M, Giobbie-Hurder A, Hatabu H,  et al. Incidence of programmed cell eeath 1 inhibitor-related pneumonitis in patients with advanced cancer: a systematic review and meta-analysis. JAMA Oncol, 2016, 2(12): 1607-1616.
				                                                                 | 
				                                                            
				                                                        
				                                                            
				                                                                | 12. | 
				                                                                				                                                                       
				                                                                        Fukihara J, Sakamoto K, Koyama J,  et al. Prognostic impact and risk factors of immune-related pneumonitis in patients with non-small-cell ung cancer who received programmed death 1 inhibitors. Clin Lung Cancer, 2019, 20(6): 442-450. e4.
				                                                                 | 
				                                                            
				                                                        
				                                                            
				                                                                | 13. | 
				                                                                				                                                                       
				                                                                        Suresh K, Voong KR, Shankar B,  et al. Pneumonitis in non-small cell lung cancer patients receiving immune checkpoint immunotherapy: incidence and risk factors. J Thorac Oncol, 2018, 13(12): 1930-1939.
				                                                                 | 
				                                                            
				                                                        
				                                                            
				                                                                | 14. | 
				                                                                				                                                                       
				                                                                        Cho JY, Kim J, Lee JS,  et al. Characteristics, incidence, and risk factors of immune checkpoint inhibitor-related pneumonitis in patients with non-small cell lung cancer. Lung Cancer, 2018, 125: 150-156.
				                                                                 | 
				                                                            
				                                                        
				                                                            
				                                                                | 15. | 
				                                                                				                                                                       
				                                                                        Gomatou G, Tzilas V, Kotteas E,  et al. Immune checkpoint inhibitor-related pneumonitis. Respiration, 2020, 99(11): 932-942.
				                                                                 | 
				                                                            
				                                                        
				                                                            
				                                                                | 16. | 
				                                                                				                                                                       
				                                                                        Nishino M, Ramaiya NH, Awad MM,  et al. PD-1 inhibitor-related pneumonitis in advanced cancer patients: radiographic patterns and clinical course. Clin Cancer Res, 2016, 22(24): 6051-6060.
				                                                                 | 
				                                                            
				                                                        
				                                                            
				                                                                | 17. | 
				                                                                				                                                                       
				                                                                        Rossi SE, Erasmus JJ, McAdams HP,  et al. Pulmonary drug toxicity: radiologic and pathologic manifestations. Radiographics, 2000, 20(5): 1245-1259.
				                                                                 | 
				                                                            
				                                                        
				                                                            
				                                                                | 18. | 
				                                                                				                                                                       
				                                                                        Chuzi S, Tavora F, Cruz M,  et al. Clinical features, diagnostic challenges, and management strategies in checkpoint inhibitor-related pneumonitis. Cancer Manag Res, 2017, 9: 207-213.
				                                                                 | 
				                                                            
				                                                        
				                                                            
				                                                                | 19. | 
				                                                                				                                                                       
				                                                                        Camiciottoli G, Orlandi I, Bartolucci M,  et al. Lung CT densitometry in systemic sclerosis: correlation with lung function, exercise testing, and quality of life. Chest, 2007, 131(3): 672-681.
				                                                                 | 
				                                                            
				                                                        
				                                                            
				                                                                | 20. | 
				                                                                				                                                                       
				                                                                        Salaffi F, Carotti M, Bosello S,  et al. Computer-aided quantification of interstitial lung disease from high resolution computed tomography images in systemic sclerosis: correlation with visual reader-based score and physiologic tests. Biomed Res Int, 2015, 2015: 834262.
				                                                                 | 
				                                                            
				                                                        
				                                                            
				                                                                | 21. | 
				                                                                				                                                                       
				                                                                        Wu XP, Kim GH, Salisbury ML,  et al. Computed tomographic biomarkers in idiopathic pulmonary fibrosis. The future of auantitative analysis. Am J Respir Crit Care Med, 2019, 199(1): 12-21.
				                                                                 |